SG
GILD icon

Swarthmore Group’s Gilead Sciences GILD Stock Holding History

Swarthmore Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,925
Closed -$237K – 54
2017
Q3 		$237K Buy
+2,925
New +$224K 0.05% 54
2015
Q1 		– Sell
-211,700
Closed -$20M – 54
2014
Q4 		$20M Sell
211,700
-182,375
-46% -$18.9M 1.81% 23
2014
Q3 		$41.9M Sell
394,075
-40,325
-9% -$3.95M 3.89% 8
2014
Q2 		$36M Buy
434,400
+20,850
+5% +$1.62M 3.79% 10
2014
Q1 		$29.3M Sell
413,550
-28,500
-6% -$2.24M 3.47% 17
2013
Q4 		$33.2M Sell
442,050
-53,950
-11% -$3.76M 3.87% 9
2013
Q3 		$31.2M Sell
496,000
-52,825
-10% -$3.16M 3.99% 10
2013
Q2 		$28.1M Buy
+548,825
New +$28.6M 3.56% 11

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swarthmore Group's GILD Position: Q4 2017 in Review

Swarthmore Group sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 2,925 shares — an estimated $237K sold.

Swarthmore Group first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $41.9M in Q3 2014. 1,575 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Swarthmore Group reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Swarthmore Group sold 2,925 Gilead Sciences shares in Q4 2017, an estimated $237K.
  • Swarthmore Group first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
  • Swarthmore Group's Gilead Sciences position peaked at $41.9M in Q3 2014.
  • 1,575 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Swarthmore Group's 13F filing for Q4 2017, filed 18 Jan 2018.